Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Lawreen H. Connors, PhD
Researcher Director
Alan and Sandra Gerry
Amyloid Research Laboratory
Amyloidosis Center
Boston University School of Medicine
72 East Concord Street, K-503
Boston, Massachusetts, United States
Dr. Connors completed her graduation from Boston College and Master’s from Tufts University, followed by Ph.D from Boston University.
She is currently Director at Alan and Sandra Gerry Amyloid Research Laboratory, Amyloidosis Center and Co-director at Amyloid Pathology and Molecular Testing Laboratory, Boston Medical Center. She is also a member of the International Society for Amyloidosis.
Lawreen Connors is affiliated with the Department of Pathology and Laboratory Medicine, Boston University School of Medicine (BUSM) and the Department of Biochemistry, BUSM.
Her research mainly focuses on understanding the amyloidogenic nature of transthyretin (TTR), normally a soluble protein present in plasma and cerebral spinal fluid. The research investigations are aimed at identifying specific factors required to initiate the disease process; these factors likely include structural features that are both intrinsic and extrinsic to TTR. Specific areas of interest include the roles of amino acid alterations, post-translational modifications (glycosylation, sulfonation, cysteinylation) and heteroassociations in TTR amyloid fibril formation.
Representative Publications:
Hereditary Renal Amyloidosis Associated With a Novel Apolipoprotein A-II Variant
myBinderRelated Content
-
SCMR Partners With Foundation to Promote March as Amyloidosis Awareness MonthThe Society for Cardiovascular Magnetic ...
-
Miami Cancer InstituteMiami Cancer Institute forges new grou...
-
FACES of Amyloidosis 2020https://www.youtube.com/watch?v=cDVYjUnq...
-
Mayo Clinic – MinnesotaMayo Clinic Minnesota is a nonprofit org...
-
Scarborough Health Network (SHN) Cardiac Amyloidosis ClinicAt Scarborough Health Network, caring fo...
-
Wilmot Cancer InstituteUR Medicine’s Wilmot Cancer Institute ...
-
Hereditary Amyloidosis CanadaThe Hereditary Amyloidosis Canada (HAC) ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
